278 related articles for article (PubMed ID: 12362293)
21. [Treatment of recurrent HCV infection after liver transplantation].
Ostojić R
Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
[TBL] [Abstract][Full Text] [Related]
22. Natural history of hepatitis C and outcomes following liver transplantation.
Rodriguez-Luna H; Vargas HE
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):51-9. PubMed ID: 15719006
[TBL] [Abstract][Full Text] [Related]
23. Course and treatment of recurrent Hepatitis C after liver transplantation.
Neumann UP; Neuhaus P
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):61-6. PubMed ID: 15719007
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C: magnitude of the problem.
Rakela J; Vargas HE
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S3-6. PubMed ID: 12362291
[TBL] [Abstract][Full Text] [Related]
25. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
26. Management of recurrence of hepatitis C infection following liver transplantation.
Charlton M
Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
28. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
29. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
30. Are posttransplantation protocol liver biopsies useful in the long term?
Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
[TBL] [Abstract][Full Text] [Related]
32. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
33. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.
Brillanti S; Vivarelli M; De Ruvo N; Aden AA; Camaggi V; D'Errico A; Furlini G; Bellusci R; Roda E; Cavallari A
Liver Transpl; 2002 Oct; 8(10):884-8. PubMed ID: 12360428
[TBL] [Abstract][Full Text] [Related]
34. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
35. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation.
Berenguer M; Prieto M; Rayón JM; Mora J; Pastor M; Ortiz V; Carrasco D; San Juan F; Burgueño MD; Mir J; Berenguer J
Hepatology; 2000 Oct; 32(4 Pt 1):852-8. PubMed ID: 11003634
[TBL] [Abstract][Full Text] [Related]
36. Recurrent hepatitis C virus infection after liver transplantation: natural course, therapeutic approach and possible mechanisms of viral control.
Gruener NH; Jung MC; Schirren CA
J Antimicrob Chemother; 2004 Jul; 54(1):17-20. PubMed ID: 15190032
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of hepatitis C virus recurrence in the liver allograft.
McCaughan GW; Zekry A
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S7-S13. PubMed ID: 12362292
[TBL] [Abstract][Full Text] [Related]
38. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation.
McCaughan GW; Zekry A
Liver Transpl; 2003 Nov; 9(11):S21-7. PubMed ID: 14586891
[TBL] [Abstract][Full Text] [Related]
39. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
McCaughan GW; Shackel NA; Bertolino P; Bowen DG
Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
[TBL] [Abstract][Full Text] [Related]
40. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
